Programme Members
Programme Contacts
University of Cambridge
Cancer Research UK Cambridge Institute
Ovarian Programme Co-Lead
University of Cambridge
Department of Oncology
Ovarian Programme Co-Lead
University of Cambridge
Department of Oncology
Programme Manager
Selected publications
-
Diagn Interv Imaging13 Dec 2018
-
Cancer Res17 Dec 2018
-
Cancer Discov13 Nov 2018
-
Sci Transl Med7 Nov 2018
-
Cancer Epidemiol Biomarkers Prev1 Apr 2018
- All members
- Group leaders
- Clinical consultants
Cambridge University Hospitals NHS Foundation Trust
Department of Radiology
PI:
N
CC:
N
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Oncology
Co-ordinate the ovarian tissue microarray projects for the SEARCH, TRICON8 and ICON7 studies.
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Obstetrics and Gynaecology
PI:
N
CC:
Y
University of Cambridge
Department of Public Health and Primary Care
Strangeways Research Laboratory
My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the...
PI:
Y
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Surgery
.
PI:
N
CC:
Y
University of Cambridge
Department of Public Health and Primary Care
My research focuses on the statistical analyses of BRCA1 and BRCA2 gene mutation carriers, primarily through data obtained by the...
PI:
N
CC:
N
University of Cambridge
Department of Obstetrics and Gynaecology
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Obstetrics and Gynaecology
PI:
N
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
Cancer Services, Cambridge University Hospitals
Ovarian cancer has a disproportionately high health care burden because of low cure rates and frequent symptoms caused by recurrent bulky...
PI:
Y
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Oncology
My cancer related research is focused on the molecular mechanisms underlying the progression from endometriosis to clear cell ovarian...
PI:
Y
CC:
N
University of Cambridge
Department of Oncology
Early Cancer Institute
PI:
N
CC:
N
University of Cambridge
Department of Public Health and Primary Care
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Obstetrics and Gynaecology, Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Haematology
Human papilloma virus infection and development of disease Response to therapy in ovarian and cervical cancer Surgical technique Comorbidity
PI:
N
CC:
Y
University of Cambridge
Department of Oncology
PI:
Y
CC:
N
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Department of Clinical Biochemistry, Department of Oncology
Wellcome MRC Institute of Metabolic Science
Cambridge University Hospitals NHS Foundation Trust
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Radiology
CRUK Cambridge Institute
Cambridge University Hospitals NHS Foundation Trust
PI:
N
CC:
N
University of Cambridge
Department of Oncology
My main area of work is the development of a software pipeline for the automated analysis and variant calling from Next Generation...
PI:
N
CC:
N
University of Cambridge, GlaxoSmithKline
Cancer Research UK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Public Health and Primary Care
PI:
N
CC:
N
University of Cambridge
MRC Biostats Unit
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Radiology
PI:
N
CC:
Y
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
Addenbrookes Hospital
PI:
N
CC:
N
University of Cambridge
Department of Oncology
Early Cancer Institute
PI:
N
CC:
N
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
Ovarian cancer
PI:
N
CC:
N
University of Cambridge
Department of Oncology
Strangeways Research Laboratory
My current research focusses on understanding the role of genetic variants played in breast cancer prognosis and side effects of...
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Department of Radiology
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK Cambridge Institute
PI:
N
CC:
Y
University of Cambridge
Department of Oncology
With the support of funding from UK Research and Innovation and Cancer Research UK, the Kar group primarily studies inherited or germline...
PI:
N
CC:
N
University of Cambridge
MRC Biostats Unit
I have interests in Bayesian methods for unsupervised genomic dataset integration, and many broad aspects of statistical and mathematical...
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Department of Public Health and Primary Care
Centre for Cancer Genetic Epidemiology
Genetic association studies in order to identify common genetic variants that modify breast and ovarian cancer risk in BRCA1 and BRCA2...
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
Elizabeth Kyran
PI:
N
CC:
N
University of Cambridge
Department of Medical Genetics
Hormonal treatment and resistance in Breast cancer
Heritable cancer predisposition
NGS data analysis
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Obstetrics and Gynaecology, Department of Oncology
Cambridge University Hospitals NHS Foundation Trust
PI:
N
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
European Bioinformatics Institute
Not applicable/other
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
Y
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute, Department of Applied Mathematics and Theoretical Physics, Department of Oncology
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
I am a Research Associate (postdoc) in the Brenton and Markowetz labs at Cancer Research UK Cambridge Institute, University of Cambridge...
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
We develop computational approaches for the systems genetics of cancer. To identify drivers of cancer we link genetic data to molecular and...
PI:
Y
CC:
N
Other
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
Y
CC:
N
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
PI:
N
CC:
N
Other
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Oncology, Department of Obstetrics and Gynaecology
PI:
N
CC:
Y
University of Cambridge
Department of Public Health and Primary Care
Strangeways Research Laboratory
I am interested in the architecture of genetic susceptibility to common cancers (primarily breast, ovarian and colorectal). I am also...
PI:
Y
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
I’m a molecular biologist focus on translational research in high grade serous ovarian cancer (HGSOC). I work on identification of genomic...
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Applied Mathematics and Theoretical Physics, Department of Oncology
PI:
N
CC:
N
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Not applicable/other
Department of Gynaecological Oncology
Main research activites have been in prevention of gynaecological cancers and specifically cervical cancer. We have international...
PI:
N
CC:
Y
University of Cambridge
Department of Oncology
I am working on genetic susceptibility to the risk of ovarian cancer and clinical outcome after a diagnosis of ovarian cancer. I have led...
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
.
PI:
N
CC:
Y
CRUK Therapeutic Discovery Laboratories
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
PI:
N
CC:
N
Investigation of genetic risk factors of ovarian cancer and am involved in OCAC (Ovarian Cancer Association Consortium). Development of...
PI:
N
CC:
N
I am interested in developing new models of high grade serous ovarian cancer that will aid to decipher the mechanisms of chemoresistance.
PI:
N
CC:
N
